標題
返回
確定
Topics
Business
Business
PR Newswire
AI & Semiconductor
AI & Semiconductor
Taiwan
Taiwan
Politics
Defense
Life
China
China
World
World
Editorial
Editorial
Topics
Business
Business
PR Newswire
AI & Semiconductor
AI & Semiconductor
Taiwan
Taiwan
Politics
Defense
Life
China
China
World
World
Editorial
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Home
Vcare PharmaTech
#
Vcare PharmaTech
About 3 search results
Sort by Date
Business
PR Newswire
Key Milestone Achieved: NDA for Sumecigrel Capsule, an Antiplatelet Innovative Drug by Vcare PharmaTech, Officially Accepted
NANJING, China
PR Newswire
2026-06-26 22:30
Sumecigrel Capsule
Vcare PharmaTech
antiplatelet drug
Business
PR Newswire
Everest Medicines Enters into Exclusive Asia-Pacific Licensing Agreement with Vcare PharmaTech for Sumecigrel
SHANGHAI
PR Newswire
2026-06-09 08:21
Sumecigrel
Everest Medicines
Vcare PharmaTech
Business
PR Newswire
Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval
NANJING, China
PR Newswire
2026-06-05 22:00
Eratrectinib
Vcare PharmaTech
TRK inhibitor